Related Experiment Video
Updated: Jun 8, 2026

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025
Intracellular antimicrobial photodynamic therapy: a novel technique for efficient eradication of pathogenic bacteria
Faina Nakonechny1, Michael A Firer, Yeshayahu Nitzan
1Department of Chemical Engineering and Biotechnology, Ariel University Center of Samaria, Ariel, Israel.
Abstract:
The increasing resistance of bacteria to antibiotics is a serious problem, caused in part by excessive and improper use of these drugs. One alternative to traditional antibiotic therapy is photodynamic antimicrobial chemotherapy (PACT) which is based on the use of a photosensitizer (PS), activated by illumination with visible light. The poor penetration of visible light through the skin limits the application of PACT to the treatment of skin infections or the use of invasive procedures. To overcome this problem we report the exploitation of light emitted as a result of the chemiluminescent reaction of luminol to excite the PS and we call this process chemiluminescent photodynamic antimicrobial therapy (CPAT). We studied the effect of free and liposome-encapsulated PS (methylene blue or toluidine blue) on bacteria under excitation by either white external light or chemiluminescence emitted by free or liposome-enclosed luminol. PACT showed slightly better performance that CPAT for free and encapsulated PS for both types of bacteria. CPAT resulted in a three log suppression of Staphylococcus aureus and two log suppression of Escherichia coli growth. The use of CPAT may prove to be a novel and more effective form of antimicrobial therapy, particularly for internal infections not easily accessible to traditional PACT.
Insights
Chemiluminescent photodynamic antimicrobial therapy (CPAT) uses luminol light to activate photosensitizers, offering a novel approach to combat antibiotic-resistant bacteria, especially for internal infections.
Area of Science:
- Microbiology
- Biochemistry
- Medical Science
Background:
- Antibiotic resistance is a growing global health threat.
- Photodynamic antimicrobial chemotherapy (PACT) is an alternative therapy using photosensitizers (PS) activated by light.
- Limited light penetration restricts PACT to superficial infections.
Purpose of the Study:
- To explore chemiluminescent photodynamic antimicrobial therapy (CPAT) as a novel antimicrobial approach.
- To evaluate CPAT's efficacy using luminol-generated light to excite photosensitizers.
- To compare CPAT with traditional PACT for bacterial inhibition.
Main Methods:
- Investigated free and liposome-encapsulated photosensitizers (methylene blue, toluidine blue).
- Excited photosensitizers using either external white light (PACT) or luminol chemiluminescence (CPAT).
- Assessed the impact on Staphylococcus aureus and Escherichia coli growth.
Main Results:
- PACT demonstrated slightly superior performance over CPAT for both free and encapsulated PS.
- CPAT achieved a three-log reduction in Staphylococcus aureus growth.
- CPAT resulted in a two-log reduction in Escherichia coli growth.
Conclusions:
- Chemiluminescent photodynamic antimicrobial therapy (CPAT) presents a promising alternative for treating bacterial infections.
- CPAT may be particularly effective for internal infections inaccessible to conventional PACT.
- Further research into CPAT could lead to novel antimicrobial strategies against resistant bacteria.
More Related Videos
Related Concept Videos
Rapid Identification of Pathogens
Antimicrobial Effectiveness
Physical Methods for Controlling Microbial Growth: Radiation and Filtration

